Aslan Fred

Insider CIK 1909362 · ARTV President and CEO, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ARTV Artiva Biotherapeutics, In	S Sale	2026-10-06	2026-10-07	23,463	$7.20	$168.9K	1,519,606	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-10-05	2026-10-06	61,696	$6.84	$421.8K	1,543,069	SEC↗
ARTV Artiva Biotherapeutics, In	A Award deriv	2026-09-15	2026-09-15	315,000	—	$0	315,000	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2026-09-15	2026-09-15	110,000	—	$0	1,604,765	SEC↗
ARTV Artiva Biotherapeutics, In	A Award deriv	2026-09-15	2026-09-15	315,000	—	$0	315,000	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2026-09-15	2026-09-15	110,000	—	$0	1,604,765	SEC↗
ARTV Artiva Biotherapeutics, In	A Award deriv	2026-09-10	2026-09-14	155,000	—	$0	155,000	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2026-09-10	2026-09-14	45,000	—	$0	1,494,765	SEC↗
ARTV Artiva Biotherapeutics, In	A Award deriv	2026-09-10	2026-09-14	155,000	—	$0	155,000	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2026-09-10	2026-09-14	45,000	—	$0	1,494,765	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-09-08	2026-09-09	23,429	$10.92	$255.8K	1,449,765	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-09-08	2026-09-09	23,429	$10.92	$255.7K	1,449,765	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-09-03	2026-09-04	61,888	$11.16	$690.7K	1,473,194	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-09-03	2026-09-04	61,888	$11.16	$690.4K	1,473,194	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2026-05-19	2026-05-19	27,116	$9.01	$244.3K	1,535,082	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2026-02-15	2026-02-18	366,850	—	$0	1,576,798	SEC↗
ARTV Artiva Biotherapeutics, In	F Tax w/h	2026-02-15	2026-02-18	14,600	$4.00	$58.4K	1,562,198	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2025-12-15	2025-12-15	3,187	$6.00	$19.1K	1,209,948	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	100,577	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	319,331	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	113,999	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	26,450	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	257,319	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	D To issuer deriv	2025-12-12	2025-12-12	51,463	—	$0	0	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2025-12-12	2025-12-12	869,136	—	$0	1,213,135	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2025-11-17	2025-11-17	6,375	$3.38	$21.5K	343,999	SEC↗
ARTV Artiva Biotherapeutics, In	F Tax w/h	2025-11-15	2025-11-17	6,347	$3.25	$20.6K	350,374	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2025-10-17	2025-10-17	25,500	$6.00	$153.0K	356,721	SEC↗
ARTV Artiva Biotherapeutics, In	F Tax w/h	2025-08-15	2025-08-18	4,472	$2.75	$12.3K	382,221	SEC↗
ARTV Artiva Biotherapeutics, In	S Sale	2025-08-15	2025-08-18	25,500	$2.73	$69.6K	386,693	SEC↗
ARTV Artiva Biotherapeutics, In	F Tax w/h	2025-05-15	2025-08-18	4,472	$2.13	$9.5K	412,193	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2025-03-05	2025-03-07	200,000	—	$0	416,665	SEC↗
ARTV Artiva Biotherapeutics, In	A Award	2024-07-22	2024-07-22	228,905	—	$0	228,905	SEC↗
ARTV Artiva Biotherapeutics, In	A Award deriv	2024-07-18	2024-07-22	343,811	—	$0	343,811	SEC↗